Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP390409.RAh4lzcI5-ueaytgixOVOz2mY4xNIgbS_MRFUNE4kDh60130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP390409.RAh4lzcI5-ueaytgixOVOz2mY4xNIgbS_MRFUNE4kDh60130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP390409.RAh4lzcI5-ueaytgixOVOz2mY4xNIgbS_MRFUNE4kDh60130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP390409.RAh4lzcI5-ueaytgixOVOz2mY4xNIgbS_MRFUNE4kDh60130_provenance.
- NP390409.RAh4lzcI5-ueaytgixOVOz2mY4xNIgbS_MRFUNE4kDh60130_assertion description "[Furthermore, in a cohort of patients with newly diagnosed RA, elevated PAR(2) expression in both CD14+ and CD3+ cells was significantly reduced 3 months after methotrexate or sulfasalazine treatment and this reduction correlated significantly with the reduction in the 28-joint Disease Activity Scale score (p<0.05).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP390409.RAh4lzcI5-ueaytgixOVOz2mY4xNIgbS_MRFUNE4kDh60130_provenance.
- NP390409.RAh4lzcI5-ueaytgixOVOz2mY4xNIgbS_MRFUNE4kDh60130_assertion evidence source_evidence_literature NP390409.RAh4lzcI5-ueaytgixOVOz2mY4xNIgbS_MRFUNE4kDh60130_provenance.
- NP390409.RAh4lzcI5-ueaytgixOVOz2mY4xNIgbS_MRFUNE4kDh60130_assertion SIO_000772 22294633 NP390409.RAh4lzcI5-ueaytgixOVOz2mY4xNIgbS_MRFUNE4kDh60130_provenance.
- NP390409.RAh4lzcI5-ueaytgixOVOz2mY4xNIgbS_MRFUNE4kDh60130_assertion wasDerivedFrom befree-20150227 NP390409.RAh4lzcI5-ueaytgixOVOz2mY4xNIgbS_MRFUNE4kDh60130_provenance.
- NP390409.RAh4lzcI5-ueaytgixOVOz2mY4xNIgbS_MRFUNE4kDh60130_assertion wasGeneratedBy ECO_0000203 NP390409.RAh4lzcI5-ueaytgixOVOz2mY4xNIgbS_MRFUNE4kDh60130_provenance.
- befree-20150227 importedOn "2015-02-27" NP390409.RAh4lzcI5-ueaytgixOVOz2mY4xNIgbS_MRFUNE4kDh60130_provenance.